AI assistant
IRADIMED CORP — Director's Dealing 2025
Apr 7, 2025
32324_dirs_2025-04-07_37000274-8e3f-49ea-96a0-f9842e15254e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2024-06-20
Reporting Person: GLENN JOHN (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-06-20 | Restricted Stock Units | $ | M | 5796 | Disposed | Common Stock (5796) | Direct |
Footnotes
F1: When vested, restricted stock units ("RSUs") are convertible into common stock on a one-for-one basis.
F2: On April 4, 2025, the Reporting Person filed a Form 4, which inadvertently stated in Column 5 of Table II that 5,796 RSUs were acquired instead of disposed. This inadvertent misstatement has been corrected in this amended filing to note that 5,796 RSUs were disposed.
F3: On June 20, 2022, the Reporting Person received RSUs under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the Reporting Person will receive a number of shares of common stock equal to the number of RSUs that have vested.